Uterine Fibroid Treatment Device Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Uterine Fibroid Treatment Device Market, By Technology

7.1.  Uterine Fibroid Treatment Device Market, By Technology Type, 2020-2027

7.1.1.    Surgical Techniques

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Laparoscopic Techniques

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Ablation Techniques

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Embolization Technique

7.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Uterine Fibroid Treatment Device Market, By Mode of Treatment

8.1.  Uterine Fibroid Treatment Device Market, By Mode of Treatment, 2020-2027

8.1.1.    Invasive Treatment

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Minimally Invasive Treatment

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Non-invasive Treatment

8.1.3.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Uterine Fibroid Treatment Device Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Technology (2016-2027)

9.1.2.    Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.1.3.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.1.4.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Technology (2016-2027)

9.2.2.    Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.2.3.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.2.4.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.2.5.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.2.6.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Technology (2016-2027)

9.3.2.    Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.3.3.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.3.4.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.3.5.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.3.6.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Technology (2016-2027)

9.4.2.    Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.4.3.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.4.4.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.4.5.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.4.6.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Technology (2016-2027)

9.5.2.    Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.5.3.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Technology (2016-2027)

9.5.4.2.        Market Revenue and Forecast, By Mode of Treatment (2016-2027)

Chapter 10.  Company Profiles

10.1.              Medtronic

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Stryker Corporation

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Boston Scientific Corporation

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              INSIGHTEC

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              CooperSurgical Inc.

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Hologic, Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Lumenis

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms